Cartesian Therapeutics, Inc. 8-K

What Happened
Cartesian Therapeutics, Inc. announced in an 8-K that Dr. Murat Kalayoglu notified the company on March 26, 2026 that he will resign from the Board of Directors effective March 31, 2026 to pursue other opportunities. Dr. Kalayoglu joined the Board in 2023 and served as Chairman of the Science and Technology Committee and as a member of the Nominating and Corporate Governance Committee. The company said his resignation was not due to any disagreement with the company’s operations, policies, or practices.

Key Details

• Resignation notice dated March 26, 2026; effective March 31, 2026.
• Dr. Murat Kalayoglu served on the Board since 2023.
• Prior roles: Chairman of the Board’s Science and Technology Committee; member of Nominating and Corporate Governance Committee.
• Company stated the resignation was not the result of any disagreement with company operations, policies or practices.

Why It Matters
Board changes can affect corporate governance and oversight—losing the chair of the Science and Technology Committee may be meaningful for investors watching Cartesian’s R&D strategy and technical oversight. The company will need to reassign committee responsibilities or appoint a replacement director, which could be disclosed in a future filing. No financial impact or disagreements were reported in this 8-K.